January 20, 2015
A D.C. federal judge has denied a motion by Takeda Pharmaceuticals USA Inc. to bar the Food and Drug Administration from approving West-Ward Pharmaceuticals Corp.'s gout drug Mitigare, ruling that the FDA's approval did not violate statute and requires deference.